Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;35(33):e2302508.
doi: 10.1002/adma.202302508. Epub 2023 Jul 2.

Augmenting Immunogenic Cell Death and Alleviating Myeloid-Derived Suppressor Cells by Sono-Activatable Semiconducting Polymer Nanopartners for Immunotherapy

Mengbin Ding  1 , Yijing Zhang  1 , Ningyue Yu  1 , Jianhui Zhou  1 , Liyun Zhu  1 , Xing Wang  1 , Jingchao Li  1
Affiliations

Augmenting Immunogenic Cell Death and Alleviating Myeloid-Derived Suppressor Cells by Sono-Activatable Semiconducting Polymer Nanopartners for Immunotherapy

Mengbin Ding et al. Adv Mater. 2023 Aug.

Abstract

Inducing immunogenic cell death (ICD) by sonodynamic therapy (SDT) is promising for cancer immunotherapy, which however is inefficient due to oxygen depletion that compromises SDT effect and mediates recruitment of immunosuppressive myeloid-derived suppressor cells (MDSCs). The fabrication of sono-activatable semiconducting polymer nanopartners (SPNTi ) to simultaneously augment ICD and alleviate MDSCs for immunotherapy is reported. A sonodynamic semiconducting polymer, hydrophobic hypoxia-responsive tirapazamine (TPZ)-conjugate, and MDSC-targeting drug (ibrutinib) are encapsulated inside such SPNTi with surface shell of a singlet oxygen (1 O2 )-cleavable amphiphilic polymer. TPZ and ibrutinib serve as drug partners to enlarge immunotherapeutic effect. Upon sono-activation, SPNTi generate 1 O2 to break 1 O2 -cleavable polymers for in situ liberations of TPZ-conjugate and ibrutinib in tumor sites, and oxygen is consumed to create severe hypoxic tumor microenvironment, in which, TPZ-conjugate is activated for augmenting ICD action, while ibrutinib alleviates MDSCs for promoting antitumor immunological effect. In a bilateral tumor mouse model, SPNTi -mediated sono-activatable immunotherapy results in growth restraints of primary and distant tumors and noteworthy precaution of tumor metastases. This study thus provides a sono-activatable immunotherapeutic strategy with high precision and safety for cancer via overcoming post-treatment hypoxia and targeting MDSCs.

Keywords: immunogenic cell death; immunotherapy; myeloid-derived suppressor cells; semiconducting polymer nanoparticles; sono-activation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. a) M. S. Goldberg, Nat. Rev. Cancer 2019, 19, 587;
    1. b) D. J. Irvine, E. L. Dane, Nat. Rev. Immunol. 2020, 20, 321;
    1. c) N. Gong, N. C. Sheppard, M. M. Billingsley, C. H. June, M. J. Mitchell, Nat. Nanotechnol. 2021, 16, 25;
    1. d) K. Esfahani, A. Elkrief, C. Calabrese, R. Lapointe, M. Hudson, B. Routy, W. H. Miller, L. Calabrese, Nat. Rev. Clin. Oncol. 2020, 17, 504.
    1. a) X. Shi, Y. Zhang, S. Xu, S. Bai, S. Li, X. Liu, Y. Jiang, C. Liu, G. Liu, Nano Today 2022, 43, 101417;

LinkOut - more resources

-